Modeling of Diabetes and Its Clinical Impact

Journal of Diabetes Science and Technology
Katharina FritzenOliver Schnell

Abstract

Understanding all aspects of diabetes treatment is hindered by the complexity of this chronic disease and its multifaceted complications and comorbidities, including social and financial impacts. In vivo studies as well as clinical trials provided invaluable information for unraveling not only metabolic processes but also risk estimations of, for example, complications. These approaches are often time- and cost-consuming and have frequently been supported by simulation models. Simulation models provide the opportunity to investigate diabetes treatment from additional viewpoints and with alternative objectives. This review presents selected models focusing either on metabolic processes or risk estimations and financial outcomes to provide a basic insight into this complex subject. It also discusses opportunities and challenges of modeling diabetes.

References

Oct 1, 1993·Medical Decision Making : an International Journal of the Society for Medical Decision Making·F A Sonnenberg, J R Beck
Jun 6, 2000·Computer Methods and Programs in Biomedicine·G Nucci, C Cobelli
Apr 6, 2002·American Journal of Physiology. Endocrinology and Metabolism·Roman HovorkaRichard H Jones
May 22, 2002·JAMA : the Journal of the American Medical Association·UNKNOWN CDC Diabetes Cost-effectiveness Group
Nov 6, 2002·Journal of Biomedical Informatics·Leonard Schlessinger, David M Eddy
Mar 1, 2003·Diabetes Care·Jaana Lindström, Jaakko Tuomilehto
Oct 28, 2003·Diabetes Care·David M Eddy, Leonard Schlessinger
Oct 28, 2003·Diabetes Care·David M Eddy, Leonard Schlessinger
Mar 6, 2004·Diabetes Technology & Therapeutics·Anuraag R Kansal
May 6, 2004·Annals of Internal Medicine·Thomas J HoergerMichael Engelgau
Aug 31, 2004·Diabetes Care·UNKNOWN American Diabetes Association Consensus Panel
Sep 14, 2004·Health Technology Assessment : HTA·Z PhilipsJ Glanville
Sep 24, 2004·Physiological Measurement·Roman HovorkaMalgorzata E Wilinska
Jan 18, 2005·IEEE Transactions on Bio-medical Engineering·Malgorzata E WilinskaRoman Hovorka
Jul 1, 2006·Biomedical Engineering Online·A Boutayeb, A Chetouani
Aug 31, 2006·Health Economics·Alan BrennanRuth Davies
Apr 23, 2008·BMJ : British Medical Journal·Clare L GilliesKamlesh Khunti
Jun 20, 2008·Clinical Pharmacokinetics·Cornelia B Landersdorfer, William J Jusko
May 16, 2009·Journal of Diabetes Science and Technology·Boris P KovatchevClaudio Cobelli
Jan 1, 2009·IEEE Reviews in Biomedical Engineering·Claudio CobelliBoris P Kovatchev
Sep 16, 2011·Cost Effectiveness and Resource Allocation : C/E·R Brett McQueenPatrick W Sullivan
Aug 4, 2012·Diabetes Technology & Therapeutics·Jaclyn A ShepardBoris Kovatchev
May 31, 2013·Journal of Medical Economics·Michael WillisJianming He
Jun 26, 2013·Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research·Andrew J PalmerWilliam Valentine
Jul 12, 2013·CPT: Pharmacometrics & Systems Pharmacology·I AjmeraV Chelliah
Aug 6, 2013·Journal of Diabetes Science and Technology·Guido FreckmannCornelia Haug
May 31, 2014·Journal of Diabetes Science and Technology·Chiara Dalla ManClaudio Cobelli
Sep 23, 2014·Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research·Phil McEwanDavid Grant
Nov 25, 2014·Medical & Biological Engineering & Computing·Andrea FacchinettiClaudio Cobelli
Dec 2, 2014·Diabetes Technology & Therapeutics·Boris P KovatchevMarc D Breton
Mar 12, 2015·Journal of Diabetes Science and Technology·Dayu LvMarc D Breton
May 27, 2015·Diabetic Medicine : a Journal of the British Diabetic Association·A A W A van der HeijdenG Nijpels
Sep 4, 2015·Journal of Diabetes Science and Technology·Harald KirchsteigerLuigi Del Re
Oct 16, 2015·Journal of Diabetes Science and Technology·Simon Lebech CichoszOle Hejlesen
Jan 23, 2016·Clinical Pharmacokinetics·Puneet GaitondeStephan Schmidt
Aug 28, 2016·Journal of Diabetes Science and Technology·Florian ReitererLuigi Del Re
Sep 16, 2016·Journal of Diabetes Science and Technology·Steven V Edelman

❮ Previous
Next ❯

Software Mentioned

Archimedes
PRIME
MICADO

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Tidskrift för Sveriges sjuksköterskor
B Bolander
Clinical Interventions in Aging
Alice E KaneSusan E Howlett
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists
David S H Bell, Eric Allbright
© 2022 Meta ULC. All rights reserved